$MMSI
MERIT MEDICAL SYSTEMS INC Stock $mmsi

$mmsi Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000085698216000117 Filed on November 09, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q3
Revenue	$157.7M	$157.0M	$136.1M
YoY Change	13.95%	15.35%	5.65%
Cost Of Revenue	$87.50M	$89.16M	$76.88M
YoY Change	12.04%	15.97%	7.7%
Gross Profit	$70.26M	$67.82M	$59.21M
YoY Change	16.5%	14.54%	3.11%
Gross Profit Margin	44.55%	43.2%	43.51%
Selling, General & Admin	$45.80M	$53.20M	$39.20M
YoY Change	11.98%	35.71%	7.91%
% of Gross Profit	65.19%	78.45%	66.21%
Research & Development	$11.90M	$11.42M	$10.52M
YoY Change	4.39%	8.64%	21.03%
% of Gross Profit	16.94%	16.85%	17.76%
Depreciation & Amortization	$12.20M	$11.90M	$9.400M
YoY Change	25.77%	26.6%	3.3%
% of Gross Profit	17.37%	17.55%	15.88%
Operating Expenses	$57.60M	$64.83M	$50.66M
YoY Change	10.13%	27.97%	11.72%
Operating Profit	$12.60M	$2.987M	$8.547M
YoY Change	57.39%	-65.05%	-29.22%
Interest Expense	-$2.700M	$3.022M	$1.489M
YoY Change	92.86%	102.96%	-25.85%
% of Operating Profit	-21.43%	101.17%	17.42%
Other Income/Expense, Net	-$300.0K	-$2.992M	-$1.887M
YoY Change	200.0%	58.56%	3.51%
Pretax Income	$12.60M	-$5.000K	$8.547M
YoY Change	56.55%	-100.06%	-29.22%
Income Tax	$2.116M	-$978.0K	$1.842M
% Of Pretax Income	16.79%		21.55%
Net Earnings	$7.507M	$973.0K	$4.818M
YoY Change	17.13%	-79.8%	-37.94%
Net Earnings / Revenue	4.76%	0.62%	3.54%
Basic Earnings Per Share	$0.17	$0.02	$0.11
Diluted Earnings Per Share	$0.17	$0.02	$0.11
COMMON SHARES
Basic Shares Outstanding	44.59M shares	44.45M shares	44.17M shares
Diluted Shares Outstanding		45.00M shares	44.73M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.20M	$17.30M	$5.900M
YoY Change	357.14%	193.22%	-7.81%
Cash & Equivalents	$19.17M	$17.32M	$5.859M
Short-Term Investments
Other Short-Term Assets	$17.00M	$16.50M	$12.90M
YoY Change	8.97%	27.91%	3.2%
Inventory	$120.7M	$116.9M	$100.3M
Prepaid Expenses
Receivables	$80.52M	$79.70M	$68.00M
Other Receivables	$6.100M	$3.900M	$7.200M
Total Short-Term Assets	$243.4M	$234.3M	$194.3M
YoY Change	19.32%	20.55%	4.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$276.6M	$278.6M	$262.6M
YoY Change	3.28%	6.12%	6.02%
Goodwill	$211.9M	$213.1M	$184.5M
YoY Change	14.88%	15.49%	-0.01%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$28.01M	$16.30M	$14.63M
YoY Change	113.49%	11.43%	-10.43%
Total Long-Term Assets	$699.4M	$694.3M	$573.7M
YoY Change	21.69%	21.02%	2.35%
TOTAL ASSETS
Total Short-Term Assets	$243.4M	$234.3M	$194.3M
Total Long-Term Assets	$699.4M	$694.3M	$573.7M
Total Assets	$942.8M	$928.6M	$768.0M
YoY Change	21.07%	20.91%	2.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$30.60M	$30.20M	$32.30M
YoY Change	-19.47%	-6.5%	20.97%
Accrued Expenses	$45.52M	$44.93M	$39.50M
YoY Change	20.27%	13.74%	20.82%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.00M	$10.00M	$10.00M
YoY Change	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$88.33M	$86.47M	$85.89M
YoY Change	0.48%	0.68%	15.91%
LONG-TERM LIABILITIES
Long-Term Debt	$314.4M	$317.8M	$200.2M
YoY Change	59.1%	58.71%	-13.13%
Other Long-Term Liabilities	$3.730M	$4.546M	$4.849M
YoY Change	-10.08%	-6.25%	76.91%
Total Long-Term Liabilities	$318.1M	$322.3M	$205.1M
YoY Change	57.68%	57.17%	-12.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$88.33M	$86.47M	$85.89M
Total Long-Term Liabilities	$318.1M	$322.3M	$205.1M
Total Liabilities	$444.6M	$442.7M	$309.5M
YoY Change	42.22%	43.03%	-3.96%
SHAREHOLDERS EQUITY
Retained Earnings	$293.9M	$286.4M	$267.4M
YoY Change	7.35%	7.12%	10.8%
Common Stock	$206.2M	$204.6M	$196.3M
YoY Change	4.23%	4.21%	7.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$498.2M	$485.9M	$458.6M
YoY Change
Total Liabilities & Shareholders Equity	$942.8M	$928.6M	$768.0M
YoY Change	21.07%	20.91%	2.88%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	$7.507M	$973.0K	$4.818M
YoY Change	17.13%	-79.8%	-37.94%
Depreciation, Depletion And Amortization	$12.20M	$11.90M	$9.400M
YoY Change	25.77%	26.6%	3.3%
Cash From Operating Activities	$17.30M	$10.90M	$16.60M
YoY Change	38.4%	-34.34%	44.35%
INVESTING ACTIVITIES
Capital Expenditures	-$7.000M	-$5.900M	-$14.70M
YoY Change	-41.67%	-59.86%	145.0%
Acquisitions
YoY Change
Other Investing Activities	-$5.400M	-$97.00M	-$9.600M
YoY Change	-871.43%	910.42%	-2500.0%
Cash From Investing Activities	-$12.30M	-$102.9M	-$24.20M
YoY Change	8.85%	325.21%	340.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.400M	98.80M	1.500M
YoY Change	-11.11%	6486.67%	-118.29%
NET CHANGE
Cash From Operating Activities	17.30M	10.90M	16.60M
Cash From Investing Activities	-12.30M	-102.9M	-24.20M
Cash From Financing Activities	-2.400M	98.80M	1.500M
Net Change In Cash	2.600M	6.800M	-6.100M
YoY Change	-273.33%	-211.48%	177.27%
FREE CASH FLOW
Cash From Operating Activities	$17.30M	$10.90M	$16.60M
Capital Expenditures	-$7.000M	-$5.900M	-$14.70M
Free Cash Flow	$24.30M	$16.80M	$31.30M
YoY Change	-0.82%	-46.33%	78.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000856982
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44587038	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MERIT MEDICAL SYSTEMS INC
CY2015Q4	mmsi	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesTax	1000	USD
CY2016Q3	mmsi	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesTax	-382000	USD
	mmsi	Acquisition Purchasesin Accrued Expenses AcquisitionPurchasesinAccruedExpenses	1300000	USD
	mmsi	Acquisition Purchasesin Accrued Expenses AcquisitionPurchasesinAccruedExpenses	293000	USD
	mmsi	Acquisitionof Intangible Assetin Exchangefor Conversionof Equity Method Investment AcquisitionofIntangibleAssetinExchangeforConversionofEquityMethodInvestment	1010000	USD
	mmsi	Acquisitionof Intangible Assetin Exchangefor Conversionof Equity Method Investment AcquisitionofIntangibleAssetinExchangeforConversionofEquityMethodInvestment	0	USD
CY2015Q3	mmsi	Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit	58000	USD
	mmsi	Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit	-185000	USD
CY2016Q3	mmsi	Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit	94000	USD
	mmsi	Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit	-99000	USD
	mmsi	Contingentreceivablereceivedinexchangeforsaleofcostmethodinvestment Contingentreceivablereceivedinexchangeforsaleofcostmethodinvestment	0	USD
	mmsi	Contingentreceivablereceivedinexchangeforsaleofcostmethodinvestment Contingentreceivablereceivedinexchangeforsaleofcostmethodinvestment	711000	USD
CY2016Q2	mmsi	Cost Method Investments Interest Acquired Number Of Units CostMethodInvestmentsInterestAcquiredNumberOfUnits	500000	shares
CY2016Q1	mmsi	Cost Method Investments Interest Acquired Number Of Units CostMethodInvestmentsInterestAcquiredNumberOfUnits	2000000	shares
CY2016Q3	mmsi	Cost Method Investments Ownership Percentage CostMethodInvestmentsOwnershipPercentage	0.186
	mmsi	Increase Decrease Liability For Uncertain Tax Positions IncreaseDecreaseLiabilityForUncertainTaxPositions	-704000	USD
	mmsi	Increase Decrease Liability For Uncertain Tax Positions IncreaseDecreaseLiabilityForUncertainTaxPositions	-366000	USD
CY2015Q4	mmsi	Intangible Assets Net Goodwill And Other Assets Noncurrent IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent	306947000	USD
CY2016Q3	mmsi	Intangible Assets Net Goodwill And Other Assets Noncurrent IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent	415679000	USD
	mmsi	Loss On Sale And Or Abandonment Of Property And Equipment LossOnSaleAndOrAbandonmentOfPropertyAndEquipment	121000	USD
	mmsi	Loss On Sale And Or Abandonment Of Property And Equipment LossOnSaleAndOrAbandonmentOfPropertyAndEquipment	102000	USD
	mmsi	Payment Of Taxes Exchange Of Common Stock PaymentOfTaxesExchangeOfCommonStock	918000	USD
	mmsi	Payment Of Taxes Exchange Of Common Stock PaymentOfTaxesExchangeOfCommonStock	86000	USD
	mmsi	Stock Surrendered During Period Value Stock Options Exercised StockSurrenderedDuringPeriodValueStockOptionsExercised	3802000	USD
	mmsi	Stock Surrendered During Period Value Stock Options Exercised StockSurrenderedDuringPeriodValueStockOptionsExercised	346000	USD
CY2015Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	37977000	USD
CY2016Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	30192000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70292000	USD
CY2016Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	79697000	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1498000	USD
CY2016Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	809000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37846000	USD
CY2016Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44927000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	140053000	USD
CY2016Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	157797000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5487000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5039000	USD
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	39612000	USD
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	23723000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	558000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1643000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	503000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1913000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1297000	USD
CY2016Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1731000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	741000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	779000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11100000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13600000	USD
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	168000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	468000	shares
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	408000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	864000	shares
CY2015Q4	us-gaap	Assets Assets	778728000	USD
CY2016Q3	us-gaap	Assets Assets	928599000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	204003000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	234294000	USD
CY2015Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	136595000	USD
CY2016Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	139559000	USD
CY2015Q3	us-gaap	Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Basic BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareBasic	0.02
	us-gaap	Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Basic BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareBasic	0.12
CY2015Q3	us-gaap	Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Diluted BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareDiluted	0.02
	us-gaap	Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Diluted BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareDiluted	0.12
CY2015Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	673000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	5190000	USD
CY2015Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	144344000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	428881000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	99000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2321000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2709000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7355000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5859000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4177000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17318000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1496000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	13141000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44267000	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44587000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44267000	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44587000	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	197826000	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	204601000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	4127000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	14677000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1364000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	13063000	USD
CY2015Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	26292000	USD
CY2016Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	33073000	USD
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	76881000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	228271000	USD
CY2016Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	89160000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	251354000	USD
CY2016Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	328413000	USD
CY2015Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	8500000	USD
CY2016Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	9000000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	USD
CY2016Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	653000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	956000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	187000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	7025000	USD
CY2016Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	6408000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	10985000	USD
CY2016Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	21886000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27745000	USD
CY2016Q3	us-gaap	Due To Employees Current DueToEmployeesCurrent	544000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2015Q4	us-gaap	Due To Employees Current DueToEmployeesCurrent	589000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31594000	USD
CY2015Q4	us-gaap	Due From Employees Current DueFromEmployeesCurrent	217000	USD
CY2016Q3	us-gaap	Due From Employees Current DueFromEmployeesCurrent	176000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-318000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	67000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.294
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.200
CY2016Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	8000000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y7M10D
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1972000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	527000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1972000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	527000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5558000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	19788000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	20854000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	21171000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	21646000	USD
CY2015Q4	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	278000	USD
CY2015Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	39301000	USD
CY2016Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	43425000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	184472000	USD
CY2016Q3	us-gaap	Goodwill Goodwill	213069000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	28584000	USD
CY2016Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	8300000	USD
	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	13000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	59205000	USD
	us-gaap	Gross Profit GrossProfit	175474000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	67815000	USD
	us-gaap	Gross Profit GrossProfit	194769000	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	99000	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	90000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	6660000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	24646000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15764000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1800000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1842000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7253000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7300000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-978000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3149000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3100000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2905000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2237000	USD
CY2015Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	905000	USD
CY2016Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	373000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	9738000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-9018000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3524000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5166000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4046000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-183000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7017000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1693000	USD
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	298000	USD
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	500000	USD
	us-gaap	Increase Decrease In Due From Employee Current IncreaseDecreaseInDueFromEmployeeCurrent	37000	USD
	us-gaap	Increase Decrease In Due From Employee Current IncreaseDecreaseInDueFromEmployeeCurrent	-42000	USD
	us-gaap	Increase Decrease In Due To Employees Current IncreaseDecreaseInDueToEmployeesCurrent	164000	USD
	us-gaap	Increase Decrease In Due To Employees Current IncreaseDecreaseInDueToEmployeesCurrent	-50000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	218000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-514000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7432000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-220000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	776000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1591000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	602000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-251000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-776000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-3385000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	499000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	452000	USD
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	43000	USD
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	63000	USD
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	569000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	491000	shares
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	553000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	417000	shares
CY2015Q3	us-gaap	Interest Expense InterestExpense	1489000	USD
	us-gaap	Interest Expense InterestExpense	4776000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	3022000	USD
	us-gaap	Interest Expense InterestExpense	6120000	USD
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	256000	USD
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	337000	USD
	us-gaap	Interest Paid Net InterestPaidNet	4713000	USD
	us-gaap	Interest Paid Net InterestPaidNet	6223000	USD
CY2015Q4	us-gaap	Interest Rate Cash Flow Hedge Asset At Fair Value InterestRateCashFlowHedgeAssetAtFairValue	2000	USD
CY2016Q3	us-gaap	Interest Rate Cash Flow Hedge Liability At Fair Value InterestRateCashFlowHedgeLiabilityAtFairValue	982000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	59170000	USD
CY2016Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	57114000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	105999000	USD
CY2016Q3	us-gaap	Inventory Net InventoryNet	116908000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	38289000	USD
CY2016Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	45132000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8540000	USD
CY2016Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14662000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	78000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	210000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	29000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	55000	USD
CY2015Q4	us-gaap	Land Land	19307000	USD
CY2016Q3	us-gaap	Land Land	19539000	USD
CY2015Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	27561000	USD
CY2016Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	29519000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	312625000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	442659000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	778728000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	928599000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87910000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	86472000	USD
CY2015Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	768000	USD
CY2016Q3	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	402000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	207593000	USD
CY2016Q3	us-gaap	Long Term Debt LongTermDebt	327760000	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10000000	USD
CY2016Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	10000000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	270913000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2500000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	17500000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	15000000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	12500000	USD
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	10000000	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	197593000	USD
CY2016Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	317760000	USD
CY2015Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	158775000	USD
CY2016Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	171308000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7488000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	123536000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50695000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-146800000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	57005000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	36338000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	4818000	USD
	us-gaap	Net Income Loss NetIncomeLoss	17393000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	973000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17393000	USD
	us-gaap	Net Income Loss NetIncomeLoss	12615000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4818000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	973000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12615000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4818000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	17393000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	973000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	12615000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1887000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4847000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2992000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6510000	USD
CY2015Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	6799000	USD
CY2016Q3	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	3350000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	50658000	USD
	us-gaap	Operating Expenses OperatingExpenses	145981000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	64828000	USD
	us-gaap	Operating Expenses OperatingExpenses	172495000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	8547000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	29493000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2987000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	22274000	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	-129000	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	-128000	USD
CY2015Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	85000	USD
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	99000	USD
CY2016Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	USD
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	90000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13121000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16296000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-497000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-2106000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	454000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	1259000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-185000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-258000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	0	USD
	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	210000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-691000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2716000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	391000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	448000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-621000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-1421000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-103000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-984000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-242000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-553000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-40000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-383000	USD
CY2015Q4	us-gaap	Other Deferred Credits Noncurrent OtherDeferredCreditsNoncurrent	2721000	USD
CY2016Q3	us-gaap	Other Deferred Credits Noncurrent OtherDeferredCreditsNoncurrent	2593000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4148000	USD
CY2016Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4546000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-476000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-281000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-445000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1948000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	11868000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	119808000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1385000	USD
CY2015Q4	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	500000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1594000	USD
CY2016Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2000000	USD
CY2016Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	500000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39501000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26492000	USD
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5634000	USD
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7005000	USD
CY2015Q4	us-gaap	Prepaid Taxes PrepaidTaxes	2955000	USD
CY2016Q3	us-gaap	Prepaid Taxes PrepaidTaxes	3059000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5924000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4422000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	109905000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	203478000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-194000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-199000	USD
	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	0	USD
	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	1089000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	42000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	407831000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	436423000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	267778000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	278626000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	124177000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	82658000	USD
CY2015Q3	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	1000000	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	1000000	USD
CY2016Q3	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	300000	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	400000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10515000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29389000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11424000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33440000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	273764000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	286378000	USD
	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	2017000	USD
	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	0	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	136086000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	403745000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	156975000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	446123000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	39201000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	115407000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	53198000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	138556000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1643000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1913000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	21233	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	618033	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	21000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	805375	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y0M0D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y0M0D
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	466103000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	485940000	USD
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44734000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44467000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44763000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44165000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43976000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44447000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44346000	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Accounting Pronouncements</font><font style="font-family:inherit;font-size:10pt;">. In October 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-16, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory</font><font style="font-family:inherit;font-size:10pt;">, which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-16 will be effective for us on January 1, 2018. We are currently evaluating the impact of adopting ASU 2016-16 on our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued ASU No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</font><font style="font-family:inherit;font-size:10pt;">, which addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 will be effective for us on January 1, 2018 with early adoption permitted. We are assessing the impact that ASU 2016-15 is anticipated to have on our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:10pt;">. ASU 2016-09 requires companies to record excess tax benefits and deficiencies in income rather than the current requirement to record them through equity. ASU 2016-09 also allows companies the option to recognize forfeitures of share-based awards when they occur rather than the current requirement to make an estimate upon the grant of the awards. ASU 2016-09 will be effective for us on January 1, 2017. Early adoption of ASU 2016-09 will be permitted in any interim or annual period, with any adjustments reflected as of the beginning of the fiscal year of adoption. We are assessing the impact that ASU 2016-09 is anticipated to have on our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases</font><font style="font-family:inherit;font-size:10pt;">, which eliminates the current tests for lease classification under U.S. GAAP and requires lessees to recognize the right-of-use assets and related lease liabilities on the balance sheet for all leases greater than one year in duration. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. ASU 2016-02 provides that lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. Lessees and lessors may not apply a full retrospective transition approach. We are assessing the impact that ASU 2016-02 is anticipated to have on our consolidated financial statements, and we currently expect that most of our operating lease commitments will be subject to the new standard and recognized as lease liabilities and right-of-use assets upon our adoption of ASU 2016-02.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU No. 2016-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities, </font><font style="font-family:inherit;font-size:10pt;">which amends the guidance regarding the classification and measurement of financial instruments. Changes to the current guidance primarily affect the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. In addition, ASU 2016-01 clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. ASU 2016-01 will be effective for us on January 1, 2018. Early adoption is not permitted except for the provision to record fair value changes for financial liabilities under the fair value option resulting from instrument-specific credit risk in other comprehensive income. Upon adoption of ASU 2016-01, an entity should apply the amendments by means of a cumulative-effect adjustment to the balance sheet at the beginning of the first reporting period in which the guidance is effective. We do not presently anticipate that the adoption of ASU 2016-01 will have a material impact on our financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2015, the FASB issued Accounting Standards Update ASU 2015-17, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes</font><font style="font-family:inherit;font-size:10pt;">, which will require deferred tax assets and deferred tax liabilities to be presented as noncurrent within a classified balance sheet. ASU 2015-17 simplifies the current guidance which requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified balance sheet. The current requirement that deferred tax assets and liabilities of a tax-paying component of an entity be offset and presented as a single amount is not affected. ASU 2015-17 will be effective for us as of January 1, 2017 with early application permitted. ASU 2015-17 may be applied either prospectively to all deferred tax assets and liabilities or retrospectively to all periods presented. We have elected not to early adopt ASU 2015-17, and we are evaluating whether to apply the provisions prospectively or retrospectively upon adoption. We do not presently anticipate that the adoption of ASU 2015-17 will have a material impact on our financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued ASU 2015-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying the Measurement of Inventory</font><font style="font-family:inherit;font-size:10pt;">. ASU 2015-11 requires that inventory be measured at the lower of cost or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Inventory measured using last-in, first-out or the retail inventory method are excluded from the scope of ASU 2015-11 which is effective for fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. We do not anticipate that the implementation of ASU 2015-11 will have a material impact on our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued authoritative guidance amending the FASB Accounting Standards Codification and creating a new Topic 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">. The new guidance clarifies the principles for recognizing revenue and develops a common revenue standard for U.S. GAAP applicable to revenue transactions. This guidance provides that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The existing industry guidance will be eliminated when the new guidance becomes effective and annual disclosures will be substantially revised. Additional disclosures will also be required under the new standard. In July 2015, the FASB approved a proposal that extended the required implementation date one year to the first quarter of 2018 but also would permit companies to adopt the standard at the original effective date of January 1, 2017. The FASB has issued several updates to the standard which (i) clarify the application of the principal versus agent guidance (ASU 2016-08); (ii) clarify the guidance on inconsequential and perfunctory promises and licensing (ASU 2016-10) and (iii) narrow scope improvements and practical expedients (ASU 2016-12). Implementation of the new standard may be either through retrospective application to each period from the first quarter of 2016 or with a cumulative effect adjustment upon adoption in 2018. We are assessing the impact this new standard is anticipated to have on our consolidated financial statements.</font></div></div>

Files In Submission

Name	View Source	Status
0000856982-16-000117-index-headers.html	Edgar Link	pending
0000856982-16-000117-index.html	Edgar Link	pending
0000856982-16-000117.txt	Edgar Link	pending
0000856982-16-000117-xbrl.zip	Edgar Link	pending
a2015mmsilogoaa06.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mmsi-09302016x10q.htm	Edgar Link	pending
mmsi-09302016x10qxex311.htm	Edgar Link	pending
mmsi-09302016x10qxex312.htm	Edgar Link	pending
mmsi-09302016x10qxex321.htm	Edgar Link	pending
mmsi-09302016x10qxex322.htm	Edgar Link	pending
mmsi-20160930.xml	Edgar Link	completed
mmsi-20160930.xsd	Edgar Link	pending
mmsi-20160930_cal.xml	Edgar Link	unprocessable
mmsi-20160930_def.xml	Edgar Link	unprocessable
mmsi-20160930_lab.xml	Edgar Link	unprocessable
mmsi-20160930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MMSI
MERIT MEDICAL SYSTEMS INC Stock $mmsi

2016 Q4 Form 10-Q Financial Statement

#000085698216000117 Filed on November 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMSI MERIT MEDICAL SYSTEMS INC Stock $mmsi

2016 Q4 Form 10-Q Financial Statement

#000085698216000117 Filed on November 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMSI
MERIT MEDICAL SYSTEMS INC Stock $mmsi